A preliminary randomized controlled clinical study on the effect of botulinum toxin A on fat breast augmentation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054878

Enrollment

Unknown

Registered

2021-12-28

Start date

2018-01-01

Completion date

Unknown

Last updated

2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast dysplasia

Interventions

Experimental group:Combined injection of botulinum toxin in the fat

Control group:No

Eligibility

Sex/Gender

Female

Age

19 Years to 49 Years

Inclusion criteria

Inclusion criteria: Patients with bilateral breast dysplasia and requiring autologous fat breast augmentation.

Exclusion criteria

Exclusion criteria: 1. The operation area has been treated with other treatments, or has undergone multiple fat fillings; 2. Allergies; 3. History of connective tissue disease; 4. Using hormones or chemotherapy drugs; 5. History of diabetes; 6. Combined with other combined operations, such as breast augmentation; 7. Patients who cannot be followed up for more than 3 months; 8. Those with greater changes in BMI before and after surgery; 9. Can not guarantee on-time treatment, failure to cooperate.

Design outcomes

Primary

Measure	Time frame
Fat retention rate;	—

Countries

China

Contacts

Public ContactYi Chengang

Xijing Hospital, the Fourth Military Medical University

yichg@163.com+86 13319234501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026